OpenAI Tests ChatGPT for Science Subscription for Research Use

OpenAI is reportedly developing a new subscription tier called "ChatGPT for Science," according to references discovered on the web build by users on X. The new offering appears aimed at scientific and research use cases, potentially extending access beyond select enterprise partners to a broader range of verified academic institutions and universities. Like OpenAI's existing Teams and Enterprise tiers, the subscription will likely carry restrictions on eligibility, requiring institutional verification rather than open sign-up.

This move builds on OpenAI's recent work with GPT-Rosalind, a purpose-built model based on the GPT-5.5 architecture designed specifically for enterprise-scale life sciences research. GPT-Rosalind currently operates behind a "trusted-access deployment structure," limiting availability to vetted organizations such as pharmaceutical giant Novo Nordisk and accredited research institutions conducting public-benefit research. ChatGPT for Science would represent a broader expansion of this governance model, offering specialized grounding in scientific discoveries and peer-reviewed research to a wider institutional audience, though still gated behind verification requirements that mirror or exceed ChatGPT Enterprise's standards.

The timing aligns with OpenAI's broader strategy of upgrading and consolidating its model lineup, including recent updates to GPT-5.5 and planned retirements of legacy ChatGPT models. No official launch date has been announced, but active references on the web build suggest a public rollout could be weeks away. Researchers and security teams evaluating AI deployments should run a privacy checkup to assess data exposure when integrating third-party AI tools, verify transport-layer protections on institutional endpoints with an SSL/TLS checker, and confirm legitimate domain ownership via a WHOIS lookup to guard against spoofing of research organization credentials.